Legend: : Special Mention  : Important : Very Important : Key Development |
| |
| |
Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre.
T Al-Chalabi, S Boccato, BC Portmann, IG McFarlane, MA Heneghan, J Hepatol. 2006 Oct:575-83 |
| |
Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
F Salerno, C Cammà, M Enea, M R&oeig;ssle, F Wong, Gastroenterology. 2007 Sep:825-34 |
| |
Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.
N Kochar, D Tripathi, H Ireland, DN Redhead, PC Hayes, Gut. 2006 Nov:1617-23 |
| |
A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
A Albillos, R Bañares, M González, MV Catalina, LM Molinero, J Hepatol. 2005 Dec:990-6 |
| |
Endoscopic transpapillary nasopancreatic drainage alone to treat pancreatic ascites and pleural effusion.
DK Bhasin, SS Rana, I Siyad, U Poddar, BR Thapa, SK Sinha, B Nagi, J Gastroenterol Hepatol. 2006 Jun:1059-64 |
| |
Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy.
MS Campbell, CM Brensinger, AJ Sanyal, C Gennings, F Wong, KV Kowdley, T McCashland, KR Reddy, Hepatology. 2005 Sep:635-40 |
| |
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?
E Cholongitas, GV Papatheodoridis, M Vangeli, N Terreni, D Patch, AK Burroughs, Aliment Pharmacol Ther. 2005 Dec:1079-89 |
| |
Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites.
P Deltenre, D Lebrec, P Mathurin, Gastroenterology. 2006 Apr:1372-3; author reply 1373 |
| |
Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study.
E Cabré, JM Hernández-Pérez, L Fluvià, C Pastor, A Corominas, MA Gassull, Am J Clin Nutr. 2005 Mar:692-701 |
| |
Ascites as the first manifestation of polyarteritis nodosa.
F Hervé, F Héron, H Levesque, I Marie, Scand J Gastroenterol. 2006 Apr:493-5 |
| |
Intestinal permeability in cirrhotic patients with and without ascites.
E Kalaitzakis, JE Johansson, I Bjarnason, E Bj&oeig;rnsson, Scand J Gastroenterol. 2006 Mar:326-30 |
| |
Low gradient ascites: a seven-year course review.
F Mansour-Ghanaei, A Shafaghi, AH Bagherzadeh, MS Fallah, World J Gastroenterol. 2005 Apr 21:2337-9 |
| |
The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
G Therapondos, L Hol, F Benjaminov, F Wong, Hepatology. 2006 Sep:640-9 |
| |
The utility of lactate dehydrogenase isoenzyme pattern in the diagnostic evaluation of malignant and nonmalignant ascites.
A Sevinc, R Sari, E Fadillioglu, J Natl Med Assoc. 2005 Jan:79-84 |
| |
Total ascitic fluid leukocyte count for reliable exclusion of spontaneous bacterial peritonitis in patients with ascites.
BC Link, CG Ziske, M Schepke, IG Schmidt-Wolf, T Sauerbruch, Eur J Gastroenterol Hepatol. 2006 Feb:181-6 |
| |
Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.
G D'Amico, A Luca, A Morabito, R Miraglia, M D'Amico, Gastroenterology. 2005 Oct:1282-93 |
| Supplementary evidence: |
| |
Advances in therapy for ascites and hepatorenal syndrome
AL Gerbes, V Gulberg, Z Gastroenterol. 2005 Jan:31-4 |
| |
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.
CP Li, TS Huang, Y Chao, FY Chang, J Whang-Peng, SD Lee, World J Gastroenterol. 2004 Sep 1:2468-71 |
| |
Ascites after transplantation--a mystery.
Z Ben-Ari, Liver Transpl. 2004 Sep:1221 |
| |
Ascites and intraabdominal infection.
L Kramer, W Druml, Curr Opin Crit Care. 2004 Apr:146-51 |
| |
Ascites reinfusion dialysis (ARD) for renal failure with refractory ascites.
RL McGill, JR Bakos, RJ Marcus, Clin Nephrol. 2004 Nov:374-9 |
| |
Benefit of TIPS for patients with refractory or recidivant ascites: serum bilirubin may make the difference.
AL Gerbes, V Gulberg, Hepatology. 2005 Jan:217 |
| |
Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis
M JabBkowski, J BiaBkowska, R Koktysz, J Bartkowiak, W Stankiewicz, D Dworniak, Pol Merkuriusz Lek. 2004:149-52 |
| |
Chylous ascites: treated with total parenteral nutrition and somatostatin.
Q Huang, ZW Jiang, J Jiang, N Li, JS Li, World J Gastroenterol. 2004 Sep 1:2588-91 |
| |
Cirrhotic ascites: a review of management.
T Sivayokan, JF Dillon, Hosp Med. 2004 Jan:22-6 |
| |
Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
R Moreau, P Delègue, F Pessione, S Hillaire, F Durand, D Lebrec, DC Valla, Liver Int. 2004 Oct:457-64 |
| |
Closed extra corporal concentration and reinfusion of ascites in cirrhosis of liver patients with refractory ascites
LM Liu, YC Chi, D Zhu, XM Yang, LH Sun, Zhonghua Gan Zang Bing Za Zhi. 2004 May:314 |
| |
Comparison of percutaneous management techniques for recurrent malignant ascites.
S Rosenberg, A Courtney, AA Nemcek Jr, RA Omary, J Vasc Interv Radiol. 2004 Oct:1129-31 |
| |
Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
F Membreno, AL Baez, R Pandula, E Walser, DT Lau, J Gastroenterol Hepatol. 2005 Mar:474-81 |
| |
Dose ascites mean more severe Crohn's disease?
JU Lee, YH Kim, SY Lee, KH Kim, CH Chung, KH Kim, HJ Son, PL Rhee, JJ Kim, JC Rhee, Korean J Gastroenterol. 2004 May:304-9 |
| |
Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study.
M Guevara, R Abecasis, R Terg, Scand J Gastroenterol. 2004 Apr:385-6 |
| |
Herpes virus infection in peritoneal fluid: a case report and review of literature.
A Angel, P Jeffries, P Valente, E Hospodar, L Fowler, Diagn Cytopathol. 2005 Jan:44-6 |
| |
How to treat a first episode of ascites?
A Pariente, Gastroenterol Clin Biol. 2004 Apr:B256-65 |
| |
How to treat and to prevent spontaneous bacterial peritonitis?
JD Grangé, Gastroenterol Clin Biol. 2004 Apr:B278-86 |
| |
Infected and noninfected ascites in pediatric patients.
SM Vieira, U Matte, CO Kieling, AL Barth, CT Ferreira, AF Souza, A Taniguchi, TR da Silveira, J Pediatr Gastroenterol Nutr. 2005 Mar:289-94 |
| |
Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment
A Torre, C Terra, M Guevara, P Ginès, Gastroenterol Hepatol. 2004 Feb:8-14 |
| |
Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells.
W Yang, SE Toffa, JW Lohn, AM Seifalian, MC Winslet, Gynecol Oncol. 2005 Feb:430-8 |
| |
Malignant ascites presenting as abdominal compartment syndrome.
Y Etzion, L Barski, Y Almog, Am J Emerg Med. 2004 Sep:430-1 |
| |
Malignant ascites: past, present, and future.
RA Adam, YG Adam, J Am Coll Surg. 2004 Jun:999-1011 |
| |
Management of ascites in patients with end-stage liver disease.
S Saadeh, GL Davis, Rev Gastroenterol Disord. 2004 Fall:175-85 |
| |
Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.
S Coll, MC Vila, L Molina, MD Gimenez, C Guarner, R Solà, Eur J Gastroenterol Hepatol. 2004 Mar:347-53 |
| |
Nitric oxide and renal function in cirrhotic patients with ascites: from physiopathology to practice.
JD Grangé, X Amiot, Eur J Gastroenterol Hepatol. 2004 Jun:567-70 |
| |
Performance standards for therapeutic abdominal paracentesis.
CM Grabau, SF Crago, LK Hoff, JA Simon, CA Melton, BJ Ott, PS Kamath, Hepatology. 2004 Aug:484-8 |
| |
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
DM Heuman, SG Abou-Assi, A Habib, LM Williams, RT Stravitz, AJ Sanyal, RA Fisher, AA Mihas, Hepatology. 2004 Oct:802-10 |
| |
Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma.
K Yoneyama, H Taniguchi, Y Kiuchi, M Shibata, K Mitamura, Scand J Gastroenterol. 2004 Dec:1272-9 |
| |
Role of different techniques for the placement of Denver peritoneovenous shunt (PVS) in malignant ascites.
R Clara, D Righi, M Bortolini, S Cornaglia, MA Ruffino, C Zanon, Surg Laparosc Endosc Percutan Tech. 2004 Aug:222-5 |
| |
Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease.
I Pache, M Bilodeau, Aliment Pharmacol Ther. 2005 Mar 1:525-9 |
| |
Spontaneous bacterial peritonitis: recent data on incidence and treatment.
MA Parsi, A Atreja, NN Zein, Cleve Clin J Med. 2004 Jul:569-76 |
| |
Transjugular intrahepatic portosystemic shunt and refractory ascites
M Guevara, C Alessandria, J Uriz, Gastroenterol Hepatol. 2004 Apr:285-91 |
| |
Treatment of ascites and the hepatorenal syndrome
M Guevara, Acta Gastroenterol Latinoam. 2004:27-35 |
| |
Understanding the mechanisms of paracentesis-induced crculatory dysfunction.
J Sola-Vera, J Such, Eur J Gastroenterol Hepatol. 2004 Mar:295-8 |